Skip to main content
main-content

Adis Journal Club

Monthly selections from the Adis journal portfolio to complement your practice


Welcome to Adis Journal Club
 

Browse a selection of peer-reviewed articles from across the Adis journal portfolio. Collated by the editors, and updated monthly, these articles summarize the latest research and review findings for the benefit of Medicine Matters visitors.


Featured article

Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma

This study couples pharmacokinetic modeling of initial doses used in the first human study of the B-cell maturation antigen × CD3 bispecific antibody teclistamab with data from a patient-derived ex vivo cytotoxicity assay to predict the efficacious therapeutic dosing range of teclistamab. 
The featured article was funded by Janssen Research & Development.


Who is Adis?
 

Published by Springer Healthcare, Adis comprises over 30 peer-reviewed, high-quality medical journals dedicated to the publication of research and reviews on drugs and other therapeutic interventions.
It includes several leading titles in clinical medicine, health economics, drug safety and pharmacokinetics.


Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox